Conference Material
|
Video
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
Mansoor H,
Hirani N,
Chavan VV,
Joshi A,
Oswal V,
Sharma J,
Iyer AS,
England K,
Ndlovu Z,
Silsarma A,
Isaakidis P,
Morales M
Share
Share
Countries
India
Subject Area
antibiotic resistance
tuberculosis
diagnostics
genetics & genomics
antimicrobial resistance
Languages
English
DOI
10.57740/3gdn-kn91
Published Date
07 Jun 2022
Conference
MSF Scientific Days International 2022
Linked Content
Conference Material
|
Slide Presentation
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Conference Material
|
Abstract
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Similar Content
Slide Presentation
|
Slide Presentation
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Abstract
|
Abstract
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Loading...